131 related articles for article (PubMed ID: 25287740)
21. Insight into glycyrrhetinic acid: the role of the hydroxyl group on liver targeting.
Tian Q; Wang X; Wang W; Zhang C; Liu Y; Yuan Z
Int J Pharm; 2010 Nov; 400(1-2):153-7. PubMed ID: 20813176
[TBL] [Abstract][Full Text] [Related]
22. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
[TBL] [Abstract][Full Text] [Related]
23. Glycyrrhetinic acid-functionalized degradable micelles as liver-targeted drug carrier.
Huang W; Wang W; Wang P; Zhang CN; Tian Q; Zhang Y; Wang XH; Cha RT; Wang CH; Yuan Z
J Mater Sci Mater Med; 2011 Apr; 22(4):853-63. PubMed ID: 21373811
[TBL] [Abstract][Full Text] [Related]
24. The role of glycyrrhetinic acid modification on preparation and evaluation of quercetin-loaded chitosan-based self-aggregates.
Du H; Liu M; Yang X; Zhai G
J Colloid Interface Sci; 2015 Dec; 460():87-96. PubMed ID: 26319324
[TBL] [Abstract][Full Text] [Related]
25. Novel polyion complex micelles for liver-targeted delivery of diammonium glycyrrhizinate: in vitro and in vivo characterization.
Yang KW; Li XR; Yang ZL; Li PZ; Wang F; Liu Y
J Biomed Mater Res A; 2009 Jan; 88(1):140-8. PubMed ID: 18260143
[TBL] [Abstract][Full Text] [Related]
26. Enhanced cellular uptake of chlorine e6 mediated by stearic acid-grafted chitosan oligosaccharide micelles.
Hu FQ; Jiang XH; Huang X; Wu XL; Yuan H; Wei XH; Du YZ
J Drug Target; 2009 Jun; 17(5):384-91. PubMed ID: 19343607
[TBL] [Abstract][Full Text] [Related]
27. Preparation, Optimization and
Tasharoie S; Ostad SN; Amini M; Sabourian R; Gilani K
Recent Adv Drug Deliv Formul; 2024; 18(1):61-76. PubMed ID: 38362679
[TBL] [Abstract][Full Text] [Related]
28. A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies.
Hu FQ; Zhao MD; Yuan H; You J; Du YZ; Zeng S
Int J Pharm; 2006 Jun; 315(1-2):158-66. PubMed ID: 16632285
[TBL] [Abstract][Full Text] [Related]
29. N-octyl-N-arginine-chitosan (OACS) micelles for gambogic acid oral delivery: preparation, characterization and its study on in situ intestinal perfusion.
Yu F; He C; Waddad AY; Munyendo WL; Lv H; Zhou J; Zhang Q
Drug Dev Ind Pharm; 2014 Jun; 40(6):774-82. PubMed ID: 23679668
[TBL] [Abstract][Full Text] [Related]
30. The synthesis, self-assembling, and biocompatibility of a novel O-carboxymethyl chitosan cholate decorated with glycyrrhetinic acid.
Du H; Yang X; Pang X; Zhai G
Carbohydr Polym; 2014 Oct; 111():753-61. PubMed ID: 25037412
[TBL] [Abstract][Full Text] [Related]
31. Chitosan based micelle with zeta potential changing property for effective mucosal drug delivery.
Le-Vinh B; Le NN; Nazir I; Matuszczak B; Bernkop-Schnürch A
Int J Biol Macromol; 2019 Jul; 133():647-655. PubMed ID: 30986465
[TBL] [Abstract][Full Text] [Related]
32. Redox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy.
Su Y; Hu Y; Du Y; Huang X; He J; You J; Yuan H; Hu F
Mol Pharm; 2015 Apr; 12(4):1193-202. PubMed ID: 25751168
[TBL] [Abstract][Full Text] [Related]
33. Sesamol-loaded stearic acid-chitosan nanomicelles mitigate the oxidative stress-stimulated apoptosis and induction of pro-inflammatory cytokines in motor neuronal of the spinal cord through NF-ĸB signaling pathway.
Wang N; Yu H; Song Q; Mao P; Li K; Bao G
Int J Biol Macromol; 2021 Sep; 186():23-32. PubMed ID: 34214577
[TBL] [Abstract][Full Text] [Related]
34. Glycyrrhetinic acid-modified poly(ethylene glycol)-b-poly(gamma-benzyl l-glutamate) micelles for liver targeting therapy.
Huang W; Wang W; Wang P; Tian Q; Zhang C; Wang C; Yuan Z; Liu M; Wan H; Tang H
Acta Biomater; 2010 Oct; 6(10):3927-35. PubMed ID: 20438873
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.
Guo H; Zhang D; Li T; Li C; Guo Y; Liu G; Hao L; Shen J; Qi L; Liu X; Luan J; Zhang Q
J Pharm Sci; 2014 Mar; 103(3):987-93. PubMed ID: 24549734
[TBL] [Abstract][Full Text] [Related]
36. Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin.
Ye YQ; Yang FL; Hu FQ; Du YZ; Yuan H; Yu HY
Int J Pharm; 2008 Mar; 352(1-2):294-301. PubMed ID: 18096336
[TBL] [Abstract][Full Text] [Related]
37. Effect of proteins with different isoelectric points on the gene transfection efficiency mediated by stearic acid grafted chitosan oligosaccharide micelles.
Yan J; Du YZ; Chen FY; You J; Yuan H; Hu FQ
Mol Pharm; 2013 Jul; 10(7):2568-77. PubMed ID: 23679858
[TBL] [Abstract][Full Text] [Related]
38. Development of respirable nanomicelle carriers for delivery of amphotericin B by jet nebulization.
Gilani K; Moazeni E; Ramezanli T; Amini M; Fazeli MR; Jamalifar H
J Pharm Sci; 2011 Jan; 100(1):252-9. PubMed ID: 20602350
[TBL] [Abstract][Full Text] [Related]
39. Enhanced cytotoxicity of core modified chitosan based polymeric micelles for doxorubicin delivery.
Ye YQ; Chen FY; Wu QA; Hu FQ; Du YZ; Yuan H; Yu HY
J Pharm Sci; 2009 Feb; 98(2):704-12. PubMed ID: 18563810
[TBL] [Abstract][Full Text] [Related]
40. In vitro antitumour activity of stearic acid-g-chitosan oligosaccharide polymeric micelles loading podophyllotoxin.
Huang X; Huang X; Jiang XH; Hu FQ; Du YZ; Zhu QF; Jin CS
J Microencapsul; 2012; 29(1):1-8. PubMed ID: 22229874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
